Researchers identified an inhibitor that showed promise against metastatic castration-resistant prostate cancer cells. From there, they continued to untangle the web to discover multiple levels of cellular processes that were preventing the immune system from mounting a response. Break past them with this inhibitor and suddenly what’s considered an immune cold tumor turns red hot.
